AnnWardMcMahonMDPublic Health Resear

PubMed

• 2 citations
  Summary of Literature on Pediatric Real-world Evidence and Effectiveness.
  Ann W. McMahon, Kenneth Quinto, Amy P. Abernethy, Jacqueline Corrigan-Curay> ;JAMA Pediatrics. 2021 Oct 1
• 2 citations
  Methodologic approaches in studies using real-world data (RWD) to measure pediatric safety and effectiveness of vaccines administered to pregnant women: A scoping review.
  Tamar Lasky, Ann W. McMahon, Wei Hua, Richard A. Forshee> ;Vaccine. 2021 Jun 2
• 4 citations
  Drug Safety in Labeling for Pediatric Drug Development and Dose Selection in Submissions to the US Food and Drug Administration.
  Clara Kim, Kyunghun Park, Ann W. McMahon, Francis G. Green, Dionna J Green, Gilbert J. Burckart> ;Journal of Clinical Pharmacology. 2021 Jun 29
• 1 citations
  Methodologic approaches in studies using real-world data to measure pediatric safety and effectiveness of vaccines administered to pregnant women: a scoping review pro...
  Tamar Lasky, Ann W. McMahon, Wei Hua, Richard A. Forshee> ;JBI Evidence Synthesis. 2020 May 7
• 10 citations
  Acute Kidney Injury During Treatment with Intravenous Acyclovir for Suspected or Confirmed Neonatal Herpes Simplex Virus Infection
  Kevin J. Downes, Craig L K Boge, Elande Baro, Gerold T. Wharton, Kellie Liston, Brittany L. Haltzman, Hannah M. Emerson, Edwin Doe, Rosanna Fulchiero, Van L Tran, Lill...> ;The Journal of Pediatrics. 2020 Feb 6
• 10 citations
  Real-World Evidence to Assess Medication Safety or Effectiveness in Children: Systematic Review.
  Tamar Lasky, Bruce Carleton, Daniel B. Horton, Lauren E. Kelly, Dimitri Bennett, Angela S. Czaja, Dina Gifkins, Osemeke U. Osokogu, Ann W. McMahon> ;Drugs - Real World Outcomes. 2020 Feb 28
• 6 citations
  Big Data in the Assessment of Pediatric Medication Safety
  Ann W. McMahon, William O. Cooper, Jeffrey S. Brown, Bruce Carleton, Finale Doshi-Velez, Isaac S. Kohane, Jennifer L. Goldman, Mark A. Hoffman, Rishikesan Kamaleswaran...> ;Pediatrics. 2020 Feb 1
• 8 citations
  Serious Adverse Events Associated with Off-Label Use of Azithromycin or Fentanyl in Children in Intensive Care Units: A Retrospective Chart Review
  Kazeem A Oshikoya, Gerold T. Wharton, Debbie Avant, Sara L. Van Driest, Norman E. Fenn, Allison B. Lardieri, Edwin Doe, Beena G. Sood, Carol Taketomo, Phuong Lieu, Lil...> ;Paediatric Drugs. 2019 Feb 1
• 14 citations
  Duration of Pediatric Clinical Trials Submitted to the US Food and Drug Administration.
  Kanecia O. Zimmerman, P. Brian Smith, Ann W. McMahon, Jean Temeck, Debbie Avant, Dianne Murphy, Susan McCune> ;JAMA Pediatrics. 2019 Jan 1
• 33 citations
  Assessing Drug Safety in Children - The Role of Real-World Data.
  Ann W. McMahon, Gerald J. Dal Pan> ;The New England Journal of Medicine. 2018 Jun 6
• 1 citations
  Workshop on evaluation of pediatric long‐term neurocognitive development and medical products
  Ann W. McMahon, Leonard P. Kapcala, Philip H. Sheridan> ;Pharmacoepidemiology and Drug Safety. 2017 Sep 19
• 20 citations
  Development of a Pediatric Adverse Events Terminology
  Debbie S. Gipson, Eric S. Kirkendall, Brenda Gumbs-Petty, Theresa Quinn, A. Steen, Amanda Hicks, Ann W. McMahon, Savian Nicholas, Anna Zhao-Wong, Perdita Taylor-Zapata...> ;Pediatrics. 2017 Jan 1
• 34 citations
  Octreotide use and safety in infants with hyperinsulinism.
  Ann W. McMahon, Gerold T. Wharton, Paul S. Thornton, Diva D. De León> ;Pharmacoepidemiology and Drug Safety. 2017 Jan 1
• 3 citations
  Stratification, Hypothesis Testing, and Clinical Trial Simulation in Pediatric Drug Development.
  Ann W. McMahon, Kevin M. Watt, Jian Wang, Dionna J Green, Ram C. Tiwari, Gilbert J. Burckart> ;Therapeutic Innovation & Regulatory Science. 2016 Jun 2
• 3 citations
  Pediatric registries at the Food and Drug Administration: design aspects that increase their likelihood of success.
  Scott K. Winiecki, M. Isabel Tejero-Taldo, Debbie Avant, Dianne Murphy, Ann W. McMahon> ;Pharmacoepidemiology and Drug Safety. 2016 May 1
• 10 citations
  Pediatric post‐marketing safety systems in North America: assessment of the current status
  Ann W. McMahon, Gerold T. Wharton, Renan Bonnel, Mary DeCelle, Kimberley Swank, Daniela Testoni, Judith U. Cope, P B Smith, Eileen Wu, Mary Dianne Murphy> ;Pharmacoepidemiology and Drug Safety. 2015 Aug 1
• 21 citations
  Safety of octreotide in hospitalized infants.
  Daniela Testoni, Christoph P. Hornik, Megan L. Neely, Qinghong Yang, Ann W. McMahon, Reese H. Clark, P. Brian Smith> ;Early Human Development. 2015 Jul 1
• 29 citations
  Adherence to Guidelines for Glucose Assessment in Starting Second-Generation Antipsychotics
  Marsha A. Raebel, Robert B. Penfold, Ann W. McMahon, Marsha E. Reichman, Susan M. Shetterly, Glenn K. Goodrich, Susan E. Andrade, Christoph U. Correll, Tobias Gerhard> ;Pediatrics. 2014 Nov 1
• 17 citations
  Pediatric cardiovascular safety: challenges in drug and device development and clinical application.
  Katherine E. Bates, Victoria L. Vetter, Jennifer S. Li, Susan Cummins, Fernando Aguel, Christopher S. Almond, Anne M. Dubin, Josephine Elia, John Finkle, Elizabeth Hau...> ;American Heart Journal. 2012 Oct 1
• 266 citations
  Trends of Outpatient Prescription Drug Utilization in US Children, 2002–2010
  Grace Chai, Laura Governale, Ann W. McMahon, James Phillip Trinidad, Judy A. Staffa, Dianne Murphy> ;Pediatrics. 2012 Jul 1
• 63 citations
  Age and Risks of FDA–Approved Long-Acting β2-Adrenergic Receptor Agonists
  Ann W. McMahon, Mark Levenson, Bradley W McEvoy, Andrew D. Mosholder, Dianne Murphy> ;Pediatrics. 2011 Nov 1
• 11 citations
  Adverse Events Following Trivalent Inactivated Influenza Vaccination in Children: Analysis of the Vaccine Adverse Event Reporting System.
  Riyadh D. Muhammad, Penina Haber, Karen R. Broder, Zanie Leroy, Robert Ball, M. Miles Braun, Robert L. Davis, Ann W. McMahon> ;The Pediatric Infectious Disease Journal. 2011 Jan 1
• 41 citations
  Description of hypersensitivity adverse events following administration of heparin that was potentially contaminated with oversulfated chondroitin sulfate in early 2008.
  Ann W. McMahon, Robert G. Pratt, Tarek A. Hammad, Steven Kozlowski, Esther H. Zhou, Susan Lu, Corrinne G. Kulick, Tarun Mallick, Gerald J. Dal Pan> ;Pharmacoepidemiology and Drug Safety. 2010 Sep 1
• 175 citations
  Tumor necrosis factor α blockers and malignancy in children: Forty-eight cases reported to the food and drug administration
  Peter Diak, Jeffrey Siegel, Lois La Grenade, Lauren Choi, Steven Lemery, Ann W. McMahon> ;Arthritis and Rheumatism. 2010 Aug 1
• 34 citations
  Serious adverse events rarely reported after trivalent inactivated influenza vaccine (TIV) in children 6–23 months of age
  Melissa Rosenberg, Robert Sparks, Ann W. McMahon, John K. Iskander, James D. Campbell, Kathryn M. Edwards> ;Vaccine. 2009 Jul 9
• Join now to see all